Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S9 from Safety and Efficacy of Eflornithine in Patients with Gastric Precancerous Lesions: A Double-Blinded, Randomized Clinical Trial
  1. Home
  2. Publications
  3. Supplementary Table S9 from Safety and Efficacy of Eflornithine in Patients with Gastric Precancerous Lesions: A Double-Blinded, Randomized Clinical Trial

Supplementary Table S9 from Safety and Efficacy of Eflornithine in Patients with Gastric Precancerous Lesions: A Double-Blinded, Randomized Clinical Trial

Authors:
  • DMDouglas R. Morgan
    Douglas R. Morgan
  • RDRicardo L. Dominguez
    Ricardo L. Dominguez
  • DNDalton A. Norwood
    Dalton A. Norwood
  • EMEleazar E. Montalvan-Sanchez
    Eleazar E. Montalvan-Sanchez
  • MPM. Blanca Piazuelo
    M. Blanca Piazuelo
  • ARAida Rodriguez-Murillo
    Aida Rodriguez-Murillo
  • ADAlberto G. Delgado
    Alberto G. Delgado
  • JHJessica Hernandez-Marrero
    Jessica Hernandez-Marrero
  • MGMaria Gonzalez-Pons
    Maria Gonzalez-Pons
  • TBT. Mark Beasley
    T. Mark Beasley
  • MCMarcia Cruz-Correa
    Marcia Cruz-Correa
  • KWKeith T. Wilson
    Keith T. Wilson

Open Access
Publisher website
Google Scholar
  • 1 July 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1940-6207.32845728
Abstract
Supplementary Table S9 presents laboratory test abnormalities reported as adverse events, including specific analytes and event resolution by treatment arm.
Keywords
  • CANCER PREVENTION
  • CLINICAL TRIAL RESULTS
  • GASTROINTESTINAL CANCERS
  • STOMACH CANCER
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.